Supporting clinical rules engine in the adjustment of medication (SCREAM):protocol of a multicentre, prospective, randomised study

BACKGROUND: In the nursing home population, it is estimated that 1 in every 3 patients is polymedicated and given their considerable frailty, these patients are especially prone to adverse drug reactions. Clinical pharmacist-led medication reviews are considered successful interventions to improve medication safety in the inpatient setting. Due to the limited available evidence concerning the benefits of medication reviews performed in the nursing home setting, we propose a study aiming to demonstrate a positive effect that a clinical decision support system, as a health care intervention, may... Mehr ...

Verfasser: Mestres Gonzalvo, Carlota
de Wit, Hugo A J M
van Oijen, Brigit P C
Hurkens, Kim P G M
Janknegt, Rob
Schols, Jos M G A
Mulder, Wubbo J
Verhey, Frans R
Winkens, Bjorn
van der Kuy, Paul-Hugo M
Dokumenttyp: Artikel
Erscheinungsdatum: 2017
Reihe/Periodikum: Mestres Gonzalvo , C , de Wit , H A J M , van Oijen , B P C , Hurkens , K P G M , Janknegt , R , Schols , J M G A , Mulder , W J , Verhey , F R , Winkens , B & van der Kuy , P-H M 2017 , ' Supporting clinical rules engine in the adjustment of medication (SCREAM) : protocol of a multicentre, prospective, randomised study ' , BMC Geriatrics , vol. 17 , no. 1 , 35 . https://doi.org/10.1186/s12877-017-0426-3
Schlagwörter: Accidental Falls / Aged / Decision Support Systems / Clinical / Delirium / Drug-Related Side Effects and Adverse Reactions / Female / Homes for the Aged / Humans / Male / Medication Therapy Management / Netherlands / Nursing Homes / Polypharmacy / Prospective Studies / Quality Improvement / Referral and Consultation / Research Design / Safety Management / Journal Article / Multicenter Study / Randomized Controlled Trial / CONTROLLED-TRIAL / CARE / Decision support systems management / REVIEWS / ADVERSE DRUG EVENTS / ELDERLY-PEOPLE / PHARMACIST / NURSING-HOME RESIDENTS / Medication review / SYSTEMS / OUTCOMES
Sprache: Englisch
Permalink: https://search.fid-benelux.de/Record/base-29186806
Datenquelle: BASE; Originalkatalog
Powered By: BASE
Link(s) : https://cris.maastrichtuniversity.nl/en/publications/43a3c1fe-73c0-4ff9-8244-16e280fe65bc

BACKGROUND: In the nursing home population, it is estimated that 1 in every 3 patients is polymedicated and given their considerable frailty, these patients are especially prone to adverse drug reactions. Clinical pharmacist-led medication reviews are considered successful interventions to improve medication safety in the inpatient setting. Due to the limited available evidence concerning the benefits of medication reviews performed in the nursing home setting, we propose a study aiming to demonstrate a positive effect that a clinical decision support system, as a health care intervention, may have on the target population. The primary objective of this study is to reduce the number of patients with at least one event when using the clinical decision support system compared to the regular care. These events consist of hospital referrals, delirium, falls, and/or deaths. METHOD/DESIGN: This study is a multicentre, prospective, randomised study with a cluster group design. The randomisation will be per main nursing home physician and stratified per ward (somatic and psychogeriatric). In the intervention group the clinical decision support system will be used to screen medication list, laboratory values and medical history in order to obtain potential clinical relevant remarks. The remarks will be sent to the main physician and feedback will be provided whether the advice was followed or not. In the control group regular care will be applied. DISCUSSION: We strongly believe that by using a clinical decision support system, medication reviews are performed in a standardised way which leads to comparable results between patients. In addition, using a clinical decision support system eliminates the time factor to perform medication reviews as the major problems related to medication, laboratory values, indications and/or established patient characteristics will be directly available. In this way, and in order to make the medication review process complete, consultation within healthcare professionals and/or the patient ...